AI assistant
Sending…
Cartesian Therapeutics, Inc. — Director's Dealing 2017
Nov 14, 2017
33483_dirs_2017-11-13_f94fb392-2c1e-4eea-b0a3-bf9f4b08b16a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-11-09
Reporting Person: BARABE TIMOTHY C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-09 | Common Stock | P | 2500 | $9.7341 | Acquired | 4992 | Direct |
| 2017-11-10 | Common Stock | P | 2500 | $9.0019 | Acquired | 7492 | Direct |
More from Cartesian Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 9
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8